FULCRUM THERAPEUTICS
3.5700
07-10月-24 15:59:58
15 分の遅延
株式
-0.2500
-6.54%
本日の幅
3.5500 - 3.7800
ISIN
N/A
ソース
NASDAQ
-
Fulcrum Therapeutics™ to Participate in Upcoming November Investor Conferences
03 11 2021 07:00:01 提供 Nasdaq GlobeNewswire
-
28 10 2021 07:00:01 提供 Nasdaq GlobeNewswire
-
Fulcrum Therapeutics™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
01 10 2021 07:00:00 提供 Nasdaq GlobeNewswire
-
20 9 2021 07:00:00 提供 Nasdaq GlobeNewswire
-
Fulcrum Therapeutics™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
10 9 2021 07:00:00 提供 Nasdaq GlobeNewswire
-
Fulcrum Therapeutics™ Appoints Mel Hayes as Chief Commercial Officer
08 9 2021 07:00:00 提供 Nasdaq GlobeNewswire
-
Fulcrum Therapeutics™ to Participate in Upcoming Investor Conferences
02 9 2021 07:00:01 提供 Nasdaq GlobeNewswire
-
16 8 2021 16:01:00 提供 Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Announces Pricing of $125 Million Public Offering of Common Stock
11 8 2021 22:09:48 提供 Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Announces Proposed Public Offering of Common Stock
10 8 2021 16:24:01 提供 Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Reports Recent Business Highlights and Second Quarter 2021 Financial Results
10 8 2021 07:01:00 提供 Nasdaq GlobeNewswire
-
10 8 2021 07:00:02 提供 Nasdaq GlobeNewswire
-
04 8 2021 07:00:01 提供 Nasdaq GlobeNewswire
-
21 6 2021 07:00:00 提供 Nasdaq GlobeNewswire
-
Fulcrum Therapeutics to Present at the BofA Securities 2021 Virtual Health Care Conference
07 5 2021 07:00:00 提供 Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Reports Recent Business Highlights and First Quarter 2021 Financial Results
06 5 2021 07:01:00 提供 Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Appoints Christopher Morabito, M.D. as Chief Medical Officer
06 5 2021 07:00:02 提供 Nasdaq GlobeNewswire
-
29 4 2021 07:00:01 提供 Nasdaq GlobeNewswire